News

The Medical Research Council (MRC), a UK-based, publicly-funded organization has presented the initial results of the independent phase III COINa study, which did not meet its primary endpoint

Central Drugs Standard Control Organization (CDSCO) in the Karnataka has set up a new office, which brings relief to the pharmaceutical companies. Now the state has two CDSCO

TAKE Solutions, a supply chain management and life sciences products company, has signed a deal with Chennai-based Novel Therapeutics. Reportedly, this is TAKE Solutions’ first deal in Chennai

Merck Serono, a division of Germany-based Merck, has announced that Erbitux (cetuximab) has demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for

Plexxikon has reported encouraging clinical data from a phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase

Zandu Pharmaceutical has announced that the company has received approval from the shareholders for merger with Emami and Emami Infrastructure. Zandu Pharmaceutical had conducted ameeting with the company’s

STELARA (ustekinumab) has been approved by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for adults with moderate to severe plaque psoriasis. STELARA,

The US District Court for the Southern District of Indiana has upheld Eli Lilly and company’s method-of-use patents on Evista (raloxifene HCl tablets). In the case of Eli

Frutarom has announced a new satiety and obesity study using its FenuLife galactomannan ingredient and has revealed positive results. The company said that the study revealed an increase